tiprankstipranks
Advertisement
Advertisement

AU:MSB Stock Latest News

Mesoblast Ramps Up Ryoncil Sales, Advances Late-Stage Cell Therapy Pipeline
Company AnnouncementsMesoblast Ramps Up Ryoncil Sales, Advances Late-Stage Cell Therapy Pipeline
1d ago
Mesoblast Hits Phase 3 Recruitment Milestone in Chronic Back Pain Push
PremiumCompany Announcements
Mesoblast Hits Phase 3 Recruitment Milestone in Chronic Back Pain Push
2d ago
Mesoblast Director Boosts Indirect Stake in Multimillion-Dollar Share Purchase
PremiumCompany Announcements
Mesoblast Director Boosts Indirect Stake in Multimillion-Dollar Share Purchase
15d ago
Mesoblast Reports Lapse of 723,666 Options, Reducing Potential Dilution
PremiumCompany Announcements
Mesoblast Reports Lapse of 723,666 Options, Reducing Potential Dilution
15d ago
Mesoblast Issues 3.28 Million New Shares on Option Conversions
PremiumCompany Announcements
Mesoblast Issues 3.28 Million New Shares on Option Conversions
15d ago
Mesoblast Seeks ASX Quotation for 3.05 Million New Shares
PremiumCompany AnnouncementsMesoblast Seeks ASX Quotation for 3.05 Million New Shares
15d ago
Mesoblast Issues 815,000 Unquoted Options Under Employee Incentive Scheme
Premium
Company Announcements
Mesoblast Issues 815,000 Unquoted Options Under Employee Incentive Scheme
15d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
16d ago
RUM
YSS
Mesoblast acquires chimeric antigen receptor platform technology
PremiumThe Fly
Mesoblast acquires chimeric antigen receptor platform technology
16d ago
MESO
Mesoblast Secures CAR Platform to Sharpen Targeting of Cell Therapies
PremiumCompany Announcements
Mesoblast Secures CAR Platform to Sharpen Targeting of Cell Therapies
16d ago
Mesoblast receives IND clearance from FDA for Ryoncil trial
PremiumThe Fly
Mesoblast receives IND clearance from FDA for Ryoncil trial
23d ago
MESO
Mesoblast Outlines R&D Outlook and Flags Risks Around Stem Cell Pipeline
PremiumCompany Announcements
Mesoblast Outlines R&D Outlook and Flags Risks Around Stem Cell Pipeline
23d ago
Mesoblast Targets Revenue Expansion and Pipeline Upside at Inaugural R&D Day
PremiumCompany AnnouncementsMesoblast Targets Revenue Expansion and Pipeline Upside at Inaugural R&D Day
23d ago
Mesoblast Wins FDA Nod for Registrational Ryoncil Trial in Duchenne Muscular Dystrophy
Premium
Company Announcements
Mesoblast Wins FDA Nod for Registrational Ryoncil Trial in Duchenne Muscular Dystrophy
23d ago
Mesoblast Seeks ASX Quotation for 1.26 Million New Shares
Premium
Company Announcements
Mesoblast Seeks ASX Quotation for 1.26 Million New Shares
23d ago
Mesoblast reports $30.3M in Ryoncil sales in March quarter
PremiumThe Fly
Mesoblast reports $30.3M in Ryoncil sales in March quarter
24d ago
MESO
Mesoblast Plans New Share Issue to Raise Capital
PremiumCompany Announcements
Mesoblast Plans New Share Issue to Raise Capital
24d ago
Mesoblast reports March quarter Ryoncil sales of $30.3M
PremiumThe Fly
Mesoblast reports March quarter Ryoncil sales of $30.3M
24d ago
MESO
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
1M ago
NVS
PEW
Mesoblast Earnings Call: Ryoncil Momentum, Pipeline Upside
PremiumCompany AnnouncementsMesoblast Earnings Call: Ryoncil Momentum, Pipeline Upside
1M ago
Mesoblast CEO Granted Additional Options Following Shareholder Approval
Premium
Company Announcements
Mesoblast CEO Granted Additional Options Following Shareholder Approval
1M ago
Mesoblast Issues 3.25 Million Unquoted Options Under Employee Incentive Scheme
Premium
Company Announcements
Mesoblast Issues 3.25 Million Unquoted Options Under Employee Incentive Scheme
1M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >